巴库基醇调节乙胆的合成,并减轻Aβ蛋白毒性
Sachin Ranjan1,2, Shalini Trivedi1, Shruti Sharma1
1Ageing Biology Lab, Microbial Technology and Nematology Department, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India.
Natural product research
|October 19, 2023
概括
巴库基醇是Psoralea corylifolia中的一个分子,增强了乙胆的传播,减少了氧化应激,并延长了寿命. 它调节涉及神经传播的关键基因,并降低有害的粉样β和脂质水平.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 乙胆 (ACh) 传输对于记忆和学习等认知功能至关重要.
- 胆功能障碍与各种神经系统疾病有关.
- 诺托罗普植物分子为提高ACH水平提供了一个有前途的治疗途径.
研究的目的:
- 识别和描述一个活性植物分子来增强ACH传播.
- 为了研究巴库基醇对ACh水平,氧化应激和寿命的影响.
- 阐明Bakuchiol神经保护作用背后的分子机制.
主要方法:
- 来自Psoralea corylifolia的巴库基的鉴定.
- 检测甲基转移和活性氧物种 (ROS) 水平.
- 对参与胆性通路的基因mRNA表达的分析 (胆载体,胆乙转移酶,乙胆载体).
- 评估粉样β和脂质水平,以及hsf-1和lgg-1的基因表达.
主要成果:
- 巴库基醇显著增加了ACh的传播,并降低了ROS水平.
- 植物分子在研究模型中延长了寿命.
- 基醇调节的mRNA表达与胆运输和ACH合成/运输相关的基因.
- 它降低了粉样β和脂质水平,可能是通过对hsf-1和自 (lgg-1) 基因的上调调节.
结论:
- 巴库基是一种有效的植物分子,可以调节胆功能障碍.
- 它通过增强 ACh 传输和减少氧化应激来证明神经保护性质.
- 巴库基醇的机制涉及神经传播,粉样蛋白清除和自的关键基因的调节.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
698
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
698
Alzheimer's Disease: Treatment
200
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
200
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.2K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.2K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.1K
Anticholinesterase Agents: Poisoning and Treatment
889
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
889


